Compare
APUS · 1 ticker
Price
100 is the close on the leftSnapshot
best blue · worst red
APUS
Apimeds Pharmaceuticals US Inc
2.27
-0.09 (-3.81%)
Valuation
| Market Cap | $3.43M |
|---|---|
| Enterprise Value | 9.72M |
| Income | -58.17M |
| Sales | 0.00M |
| Book / share | 70.54 |
| Cash / share | 5.48 |
| Dividend Gr. 3/5Y | - - |
| Employees | 7 |
| IPO | May 09, 2025 |
Ratios
| Price / book | 0.03 |
|---|---|
| Price / cash | 0.41 |
| Quick Ratio | 0.51 |
| Current Ratio | 0.51 |
| Debt / equity | 0.14 |
| Long-term debt / equity | 0.00 |
| Options and short | No / Yes |
Earnings
| Earnings / share | -36.71 |
|---|---|
| Past earnings growth | -108.46% - |
| Past sales growth | - - |
| Earnings vs last year | -1063.72% |
| Earnings vs last quarter | -456.18% |
| Surprise | - - |
Ownership
| Insiders own | 62.68% |
|---|---|
| Insider trades | 0.00% |
| Institutions own | 2.94% |
| Return on assets | -84.20% |
| Return on equity | -100.13% |
| Return on capital | -54.59% |
| 20-day average | -23.98% |
| 50-day average | -34.04% |
| 200-day average | -77.47% |
Technical
| Shares out | 1.51M |
|---|---|
| Shares floating | 0.56M |
| Short / float | 5.68% |
| Short ratio | 0.01 |
| Short interest | 0.03M |
| 52-week high | 59.70 -96.2% |
| 52-week low | 1.51 +50.3% |
| Volatility | 9.52% 12.35% |
| Average range | 0.56 |
| Strength index | 35.11 |
| Market sensitivity | 0.25 |
| Relative volume | 0.00 |
| Avg Volume | 3.70M |
| Volume | 0 |
Performance
| Perf Week | -16.85% |
|---|---|
| Perf Month | -50.44% |
| Perf Quarter | -50.11% |
| Perf Half Y | -83.43% |
| Perf YTD | -86.16% |
| Perf Year | -91.53% |
| Prev Close | 2.27 |
| Price | 2.27 |
| Change % | 0.00% |
Compare
| APUS | |
|---|---|
| Price | 2.27 |
| Change | -0.09 (-3.81%) |
Compare · Valuation
| APUS | |
|---|---|
| Market Cap | $3.43M |
| Enterprise Value | 9.72M |
| Income | -58.17M |
| Sales | 0.00M |
| Book / share | 70.54 |
| Cash / share | 5.48 |
| Dividend Gr. 3/5Y | - - |
| Employees | 7 |
| IPO | May 09, 2025 |
Compare · Ratios
| APUS | |
|---|---|
| Price / book | 0.03 |
| Price / cash | 0.41 |
| Quick Ratio | 0.51 |
| Current Ratio | 0.51 |
| Debt / equity | 0.14 |
| Long-term debt / equity | 0.00 |
| Options and short | No / Yes |
Compare · Earnings
| APUS | |
|---|---|
| Earnings / share | -36.71 |
| Past earnings growth | -108.46% - |
| Past sales growth | - - |
| Earnings vs last year | -1063.72% |
| Earnings vs last quarter | -456.18% |
| Surprise | - - |
Compare · Ownership
| APUS | |
|---|---|
| Insiders own | 62.68% |
| Insider trades | 0.00% |
| Institutions own | 2.94% |
| Return on assets | -84.20% |
| Return on equity | -100.13% |
| Return on capital | -54.59% |
| 20-day average | -23.98% |
| 50-day average | -34.04% |
| 200-day average | -77.47% |
Compare · Technical
| APUS | |
|---|---|
| Shares out | 1.51M |
| Shares floating | 0.56M |
| Short / float | 5.68% |
| Short ratio | 0.01 |
| Short interest | 0.03M |
| 52-week high | 59.70 -96.2% |
| 52-week low | 1.51 +50.3% |
| Volatility | 9.52% 12.35% |
| Average range | 0.56 |
| Strength index | 35.11 |
| Market sensitivity | 0.25 |
| Relative volume | 0.00 |
| Avg Volume | 3.70M |
| Volume | 0 |
Compare · Performance
| APUS | |
|---|---|
| Perf Week | -16.85% |
| Perf Month | -50.44% |
| Perf Quarter | -50.11% |
| Perf Half Y | -83.43% |
| Perf YTD | -86.16% |
| Perf Year | -91.53% |
| Prev Close | 2.27 |
| Price | 2.27 |
| Change % | 0.00% |